The two drugs are not interchangeable nor dose equivalents.
Mycophenolate mofetil (Cellcept) is a semi synthetic prodrug that is rapidly hydrolyzed in vivo to form the active metabolite, mycophenolic acid (MPA).
Mycophenolate sodium (Myfortic) is an enteric-coated formulation which allows delayed release of MPA into the small intestine.
Myfortic causes less diarrhea, indigestion, and abdominal compared to CellCept.
REFERENCES:
Manger B, Hiepe F, Schneider M, et al. Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study. Clin Exp Gastroenterol. 2015;8:205-213. Published 2015 Jul 21. doi:10.2147/CEG.S81922
B-type natriuretic peptide (BNP) is a hormone created in response to cardiac wall stretch due…
A common finding described on computed tomography (CT) imaging. A disease with a peribronchovascular distribution…
Though often used synonymously; Trapped Lung and Lung Entrapment technically describe separate entities along the…
It is not clearly understood why patients with pulmonary hypertension (PH) develop pericardial effusions. However,…
Serum Creatinine can be a deceptive surrogate during an acute kidney injury. It may lag…
Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases (i.e SLE, Juvenile idiopathic…
This website uses cookies.